Effects of tocainide on ventricular fibrillation threshold: Comparison with lidocaine
- 31 July 1978
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 42 (1) , 76-81
- https://doi.org/10.1016/0002-9149(78)90988-8
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Response optimization of drug dosage: Antiarrhythmie studies with tocainideClinical Pharmacology & Therapeutics, 1977
- High-Pressure Liquid Chromatographic Analysis of Drugs in Biological Fluids II: Determination of an Antiarrhythmic Drug, Tocainide, as Its Dansyl Derivative Using a Fluorescence DetectorJournal of Pharmaceutical Sciences, 1977
- Clinical efficacy and pharmacokinetics of a new orally effective antiarrhythmic, tocainide.Circulation, 1976
- Kinetics of the oral antiarrhythmie lidocaine congener, tocainideClinical Pharmacology & Therapeutics, 1976
- Antiarrhythmic effects of a lidocaine congener, tocainide, 2‐amino‐2',6'‐propionoxylidide, in manClinical Pharmacology & Therapeutics, 1976
- Ventricular Fibrillation ThresholdArchives of internal medicine (1960), 1975
- Lidocaine in the Prevention of Primary Ventricular FibrillationNew England Journal of Medicine, 1974
- Determination of Lidocaine in Blood and TissuesAnesthesiology, 1973
- Quantitative study of the effect of lidocaine on the threshold for ventricular fibrillation in the dogThe American Journal of Cardiology, 1972
- Effect of Lidocaine on the Ventricular Fibrillation Threshold in the Dog during Acute Ischemia and Premature Ventricular ContractionsCirculation, 1972